Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23514285 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism
Conditions: Embolism, Paradoxical;   Heart Septal Defects, Atrial
Interventions: Device: Percutaneous closure of patent foramen ovale;   Drug: Medical antitrhombotic treatment

Indicates status has not been verified in more than two years